Literature DB >> 7786818

The treatment of advanced bladder cancer.

C N Sternberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7786818     DOI： 10.1093/oxfordjournals.annonc.a059105

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profiling.

Authors:  Yoichiro Kato; Hitoshi Zembutsu; Ryo Takata; Fuyuki Miya; Tatsuhiko Tsunoda; Wataru Obara; Tomoaki Fujioka; Yusuke Nakamura
Journal:  Exp Ther Med       Date:  2010-11-30       Impact factor: 2.447

2.  Treatment Response Assessment for Bladder Cancer on CT Based on Computerized Volume Analysis, World Health Organization Criteria, and RECIST.

Authors:  Lubomir Hadjiiski; Alon Z Weizer; Ajjai Alva; Elaine M Caoili; Richard H Cohan; Kenny Cha; Heang-Ping Chan
Journal:  AJR Am J Roentgenol       Date:  2015-08       Impact factor: 3.959

3.  Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?

Authors:  Kensuke Bekku; Takashi Saika; Yasuyuki Kobayashi; Ryo Kioshimoto; Taiki Kanbara; Yasutomo Nasu; Hiromi Kumon
Journal:  Int J Clin Oncol       Date:  2011-11-18       Impact factor: 3.402

Review 4.  Pharmacogenomics in bladder cancer.

Authors:  Garrett M Dancik; Dan Theodorescu
Journal:  Urol Oncol       Date:  2014-01       Impact factor: 3.498

5.  Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.

Authors:  K Boman; A H Larsson; U Segersten; E Kuteeva; H Johannesson; B Nodin; J Eberhard; M Uhlén; P-U Malmström; K Jirström
Journal:  Br J Cancer       Date:  2013-05-07       Impact factor: 7.640

6.  Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.

Authors:  Christoffer Wennersten; Gustav Andersson; Karolina Boman; Björn Nodin; Alexander Gaber; Karin Jirström
Journal:  Diagn Pathol       Date:  2014-10-03       Impact factor: 2.644

7.  Bladder Cancer Segmentation in CT for Treatment Response Assessment: Application of Deep-Learning Convolution Neural Network-A Pilot Study.

Authors:  Kenny H Cha; Lubomir M Hadjiiski; Ravi K Samala; Heang-Ping Chan; Richard H Cohan; Elaine M Caoili; Chintana Paramagul; Ajjai Alva; Alon Z Weizer
Journal:  Tomography       Date:  2016-12

8.  Deep Learning Approach for Assessment of Bladder Cancer Treatment Response.

Authors:  Eric Wu; Lubomir M Hadjiiski; Ravi K Samala; Heang-Ping Chan; Kenny H Cha; Caleb Richter; Richard H Cohan; Elaine M Caoili; Chintana Paramagul; Ajjai Alva; Alon Z Weizer
Journal:  Tomography       Date:  2019-03

Review 9.  Study Progress of Radiomics With Machine Learning for Precision Medicine in Bladder Cancer Management.

Authors:  Lingling Ge; Yuntian Chen; Chunyi Yan; Pan Zhao; Peng Zhang; Runa A; Jiaming Liu
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

10.  Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.

Authors:  Karolina Boman; Ulrika Segersten; Göran Ahlgren; Jakob Eberhard; Mathias Uhlén; Karin Jirström; Per-Uno Malmström
Journal:  BMC Urol       Date:  2013-04-08       Impact factor: 2.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.